Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
about
Treatment of CMV retinitis with intravitral ganciclovir in the HAART eraNonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirusCoresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase.The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.An algorithmic approach to treatment of cytomegalovirus retinitis.Clinically resistant cytomegalovirus retinitis.Local treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.Pitfalls and unusual manifestations of acquired immunodeficiency syndrome in the retina.Rhegmatogenous retinal detachments in patients with acquired immunodeficiency syndrome.Medical and virological aspects of ocular human immunodeficiency virus infection for the ophthalmologist.Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitisCrystallization after intravitreal ganciclovir injectionTherapeutic developments in cytomegalovirus retinitis.Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy.Management of CMV disease in HIV infection.Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.Treatment of herpesvirus infections in HIV-infected individuals.The use of antiviral drugs during the neonatal periodCurrent status of HIV therapy: II. Opportunistic diseases.Emerging therapies for herpes viral infections (types 1 - 8).Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.Local therapy for cytomegalovirus retinitis.Viral posterior uveitis.Comparison of three cell-based drug screening platforms for HSV-1 infection.Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.Treatment of human immunodeficiency virus infection and its associated complications in children.Management of cytomegalovirus infection. The Jefferiss Wing Therapeutics and Protocols Group.AIDS and the eye. A 10-year experience.DRUG THERAPY OF CYTOMEGALOVIRUS INFECTIONSPreventing and treating major opportunistic infections in AIDS. What's new and what's still true.Treatment of cytomegalovirus retinitis with intraocular implants.Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection.Concurrent use of foscarnet and ciprofloxacin may increase the propensity for seizures.Foscarnet-induced severe hypomagnesemia and other electrolyte disorders.Rapid regression of cystoid macular edema associated with cytomegalovirus retinitis in adult acute myeloid leukemia by intravitreal methotrexate combined with oral valganciclovir: A case report with comparison of binocular outcome.Treatment of cytomegalovirus retinitis: A growing number of options.Cytomegalovirus Treatment.
P2860
Q28262771-A6BF4E3D-3FDB-4BB0-B755-2771A140DEF4Q28343467-3F767838-E5DD-4502-8E66-020685066424Q28369167-F9E0A890-AE57-46C0-935A-3DE6E620D29AQ33400808-C1E7083E-7A91-4700-AE64-AAF462D238A8Q33569542-4B435044-7A43-4415-8CD0-7947E89B4CE2Q33569554-B3787411-D491-411E-8FD5-B12655E77198Q33569565-296E6F2B-9CB1-44B4-B0BA-74446DFF9238Q33569571-182DA823-D504-4837-86B2-5F6E3D9B9906Q33569587-64A34B7D-ED89-4DF4-B167-7AB1C7C51436Q33569593-65CC96F1-E61A-4E60-9AAA-43EC55B67A50Q33956406-371521D5-87CB-4F2F-9A4C-71DDC62E582CQ34043291-2C7B52B9-81EF-47F3-9A9A-1987AA6680D9Q34074692-B9DBD0B8-C3E3-4957-ADD8-A9688E748010Q34294838-147E2E59-C176-4AC3-9A9B-4A185E4C6DB0Q34660073-45C12303-D6BC-47FC-B808-4D0A57CCFC99Q34670354-678A1AC9-2516-4404-9130-3866EA257762Q35231928-C9D4CAF9-9661-43D9-AF74-6981216980E2Q35789702-C1140526-4935-4992-926F-2A834B6CF862Q35819631-3CC8E5AA-74C8-4923-8676-B24D6816B441Q35967376-73FDDEE1-1139-49D2-91F8-6645F628C5A7Q36456745-B3BF271B-0884-438E-B543-62A6C22D9126Q37151478-2878A921-200F-4B72-9D8C-599B8CDAF20FQ37544453-F992FEFD-453E-43EA-A768-5D8AAE5BD16FQ38017949-0F8E18D7-8038-424D-AF73-B3F484D2175DQ38553191-697E73B9-079E-4473-8BC9-08FABF826284Q39052924-9CCA95DD-825C-4857-BE2E-AE2741B34D7DQ40273624-EF5A1C2D-651D-4829-A214-60B6F1BAE9A3Q40669533-41D5064E-A07C-4569-AB32-991B6D06811DQ40727613-49F6294B-872E-48A3-9BD6-E3F066819912Q40938393-6B14B43A-0280-4CD4-913E-4BDF50DA03F5Q41065955-7E27908E-EB3A-46A5-8DB0-72CDC28EEE96Q41149358-0C701573-BBD5-4624-9D01-7566BCE64ED6Q41615483-7E41EFE5-49E1-4185-9F37-FE7FAAE10550Q41722152-2F64EFE2-8ABC-4C1B-8D67-2756CC43C8BCQ42235971-AFBAFF06-23A2-4025-B70E-E38DE5273415Q42282299-75A683CC-3357-40E5-9BBC-B4E31642174DQ42288776-DA0A92A8-5AE4-4B43-A16C-F6228CB42C7BQ42336629-52F5E21F-7B3C-4402-94B2-EF59B70ED1EFQ42544513-FC167044-0848-40D8-B90A-79F300DEA2AFQ42554715-48DCDAC3-B88C-42EB-8BEE-548CA0D60FFC
P2860
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Mortality in patients with the ...... for cytomegalovirus retinitis.
@en
Mortality in patients with the ...... for cytomegalovirus retinitis.
@nl
type
label
Mortality in patients with the ...... for cytomegalovirus retinitis.
@en
Mortality in patients with the ...... for cytomegalovirus retinitis.
@nl
prefLabel
Mortality in patients with the ...... for cytomegalovirus retinitis.
@en
Mortality in patients with the ...... for cytomegalovirus retinitis.
@nl
P1476
Mortality in patients with the ...... for cytomegalovirus retinitis.
@en
P2093
AIDS Clinical Trials Group
Studies of Ocular Complications of AIDS Research Group
P304
P356
10.1056/NEJM199201233260401
P407
P577
1992-01-01T00:00:00Z